Confo Therapeutics
Edit

Confo Therapeutics

http://confotherapeutics.com/
Last activity: 15.06.2023
Categories: ITHealthTechGrowthDrugBuildingActiveMedTechTechnologyWebsite
Confo Therapeutics employs its proprietary CONFO® technology to lock inherently unstable functional conformations of GPCRs as a superior starting point for drug discovery.
Mentions
30
Location: Belgium
Total raised: $40.74M

Investors 7

Funding Rounds 5

DateSeriesAmountInvestors
30.03.2021Grant$1.17M-
21.06.2019Grant$1.94M-
07.05.2019Series A$33.59MWellington...
20.02.2018Grant$1.23M-
01.02.2017-$2.8M-

Mentions in press and media 30

DateTitleDescriptionSource
15.06.2023Confo Therapeutics Enters into Research Collaboration for GP...• Collaboration to make use of Confo’s unique suite of ConfoBody®-enabled antibody discovery technol...fundplus.b...
02.03.2023Confo Therapeutics Announces Global Licensing Agreement with...Ghent, Belgium – March 2, 2023 – Confo Therapeutics, a leader in the discovery of medicines targetin...fundplus.b...
16.12.2021Confo Therapeutics Expands Patent Estate for ConfoBody®-base...Confo Therapeutics Expands Patent Estate for ConfoBody®-based GPCR Screening Platform Ghent, Belgiu...fundplus.b...
30.11.2021Confo Therapeutics Enters Collaborative Agreement with Regen...Confo Therapeutics Enters Collaborative Agreement with Regeneron — Confo will work together with Re...fundplus.b...
30.11.2021Confo Therapeutics Enters Collaborative Agreement with Regen...Confo will work together with Regeneron to apply its GPCR drug discovery platform to enable function...wellington...
30.03.2021Confo Therapeutics awarded € 1 million VLAIO grant for pre-c...Ghent, Belgium: 30 March 2021 – Confo Therapeutics announced today that it has been awarded a € 1 mi...capricorn....
15.10.2020Confo Therapeutics announces selection of first product cand...Ghent, Belgium: 15 October 2020 – Confo Therapeutics today announced the selection of its first prec...capricorn....
10.06.2020Confo Therapeutics expands Board with appointment of Rob Sco...Ghent, Belgium: 10 June 2020 – Confo Therapeutics today announced the addition of a new member to it...capricorn....
03.06.2020Confo Therapeutics appoints Paolo Vicini as Chief Developmen...New management role underscores Company’s commitment to establishing and advancing its proprietary p...capricorn....
27.02.2020Confo Therapeutics to present at Cowen 40th Annual Health Ca...Ghent, Belgium: 27 February 2020 – Confo Therapeutics, a pioneering biopharma company, today announc...capricorn....
Show more

Reviews 0

Sign up to leave a review

Sign up Log In